14-3-3σ attenuates RhoGDI2-induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells

被引:14
作者
Kim, In-Kyu [1 ]
Park, Sun-Mi [1 ]
Cho, Hee Jun [1 ]
Baek, Kyoung Eun [1 ]
Nam, In-Koo [1 ]
Park, Seung-Ho [1 ]
Ryu, Ki-Jun [1 ]
Ryu, Jinhyun [2 ,3 ]
Choi, Jungil [2 ,3 ]
Hong, Soon-Chan [4 ]
Kim, Jae Won [1 ]
Lee, Chang Won [1 ]
Kang, Sang Soo [2 ,3 ]
Yoo, Jiyun [1 ]
机构
[1] Gyeongsang Natl Univ, Grad Sch, Life Sci Res Inst, Div Appl Life Sci, Jinju, South Korea
[2] Gyeongsang Natl Univ, Sch Med, Dept Anat & Neurobiol, Inst Hlth Sci, Jinju, South Korea
[3] Gyeongsang Natl Univ, Sch Med, Med Res Ctr Neural Dysfunct, Jinju, South Korea
[4] Gyeongsang Natl Univ, Sch Med, Dept Surg, Jinju, South Korea
基金
新加坡国家研究基金会;
关键词
RhoGDI2; 14-3-3; sigma; gastric cancer; chemoresistance; metastasis; RHO GTPASES; RHOGDI2; CHEMOTHERAPY; METASTASIS; EXPRESSION; 5-FLUOROURACIL; PROTEINS; D4-GDI; ALPHA; PROGRESSION;
D O I
10.18632/oncotarget.1334
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Rho GDP dissociation inhibitor 2 (RhoGDI2) promotes tumor growth and malignant progression and enhances chemoresistance of gastric cancer. Recently, we noted an inverse correlation between RhoGDI2 and 14-3-3 sigma expression, which suggests that 14-3-3 sigma is a target of gastric cancer metastasis and the chemoresistance-promoting effect of RhoGDI2. Herein, we evaluated whether 14-3-3 sigma is regulated by RhoGDI2 and is functionally important for the RhoGDI2-induced cisplatin resistance of gastric cancer cells. We used highly metastatic and cisplatin-resistant RhoGDI2-overexpressing SNU-484 cells and observed decreased 14-3-3 sigma mRNA and protein expression. Depletion of 14-3-3 sigma in SNU-484 control cells enhanced cisplatin resistance, whereas restoration of 14-3-3 sigma in RhoGDI2-overexpressing SNU-484 cells impaired cisplatin resistance in vitro and in vivo. We also found that the phosphorylation levels of Erk and p38 kinases significantly decreased in RhoGDI2-overexpressing SNU-484 cells and recovered after 14-3-3 sigma expression, and that decreased activities of these kinases were critical for RhoGDI2-induced cisplatin resistance. In conclusion, 14-3-3 sigma is a RhoGDI2-regulated gene that appears to be important for suppressing the chemoresistance of gastric cancer cells.
引用
收藏
页码:2045 / 2056
页数:12
相关论文
共 46 条
[21]  
Li ZM, 2009, AM J TRANSL RES, V1, P326
[22]   Epigenetic silencing of 14-3-3sigma in cancer [J].
Lodygin, Dmitri ;
Hermeking, Heiko .
SEMINARS IN CANCER BIOLOGY, 2006, 16 (03) :214-224
[23]   Multimodal treatment of gastric cancer [J].
Moehler, Markus ;
Galle, P. R. ;
Gockel, I. ;
Junginger, T. ;
Schmidberger, H. .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2007, 21 (06) :965-981
[24]   Rho GDP Dissociation Inhibitor 2 Suppresses Metastasis via Unconventional Regulation of RhoGTPases [J].
Moissoglu, Konstadinos ;
McRoberts, Kevin S. ;
Meier, Jeremy A. ;
Theodorescu, Dan ;
Schwartz, Martin A. .
CANCER RESEARCH, 2009, 69 (07) :2838-2844
[25]  
PRASAD GL, 1992, CELL GROWTH DIFFER, V3, P507
[26]  
Price TJ, 2012, EXPERT REV GASTROENT, V6, P199, DOI [10.1586/egh.11.103, 10.1586/EGH.11.103]
[27]   Knockdown of RhoGDIα induces apoptosis and increases lung cancer cell chemosensitivity to paclitaxel [J].
Rong, F. ;
Li, W. ;
Chen, K. ;
Li, D. M. ;
Duan, W. M. ;
Feng, Y. Z. ;
Li, F. ;
Zhou, X. W. ;
Fan, S. J. ;
Liu, Y. ;
Tao, M. .
NEOPLASMA, 2012, 59 (05) :541-550
[28]   Rho GDP dissociation inhibitor α expression correlates with the outcome of CMF treatment in invasive ductal breast cancer [J].
Ronneburg, Henrike ;
Span, Paul N. ;
Kantelhardt, Eva ;
Dittmer, Angela ;
Schunke, Dario ;
Holzhausen, Hans-Juergen ;
Sweep, Fred C. G. J. ;
Dittmer, Juergen .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 36 (02) :379-386
[29]   Recurrence in early gastric cancer with lymph node metastasis [J].
Saka, Makoto ;
Katai, Hitoshi ;
Fukagawa, Takeo ;
Nijjar, Rajwinder ;
Sano, Takeshi .
GASTRIC CANCER, 2008, 11 (04) :214-218
[30]   Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine [J].
Sakuramoto, Shinichi ;
Sasako, Mitsuru ;
Yamaguchi, Toshiharu ;
Kinoshita, Taira ;
Fujii, Masashi ;
Nashimoto, Atsushi ;
Furukawa, Hiroshi ;
Nakajima, Toshifusa ;
Ohashi, Yasuo ;
Imamura, Hiroshi ;
Higashino, Masayuki ;
Yamamura, Yoshitaka ;
Kurita, Akira ;
Arai, Kuniyoshi .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (18) :1810-1820